Skip to main content
School of Public Health
block W logo University of Washington

Joseph Unger

Affiliate Assistant Professor, Health Services

Assistant Member
Fred Hutchinson Cancer Research Center


Education

PhD   University of Washington, 2013   (Health Services Research)
MS   University of Washington, 1993   (Biostatistics)
BA   Pomona College, 1990   (Mathematics)

Contact Info

email:   ungerj3@uw.edu

address:
Fred Hutchinson Cancer Research Center
1100 Fairview Ave, N
Seattle, WA 98109

voice:   206-667-2860
fax:   206-667-4408

Cancer care delivery research; clinical trials; income disparities; clinical trial impact and generalizability; diffusion of new treatments


Unger JM, Barlow WE, Tangen CM, Ramsey SD, Thompson IM Jr, Klein EA, LeBlanc M, Blanke CD, Goodman PJ, Minasian LM, Nghiem VT, Hershman DL. The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trials. Cancer Epidemiol. 2018 Jun 21;55:117-122. doi: 10.1016/j.canep.2018.06.005. [Epub ahead of print]  PMID: 29936140
PubMed
 
DOI
 


Lambertini M, Moore HCF, Leonard RCF, Loibl S, Munster P, Bruzzone M, Boni L, Unger JM, Anderson RA, Mehta K, Minton S, Poggio F, Albain KS, Adamson DJA, Gerber B, Cripps A, Bertelli G, Seiler S, Ceppi M, Partridge AH, Del Mastro L. Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data. J Clin Oncol. 2018 Jul 1;36(19):1981-1990. doi: 10.1200/JCO.2018.78.0858. Epub 2018 May 2.  PMID: 29718793
PubMed
 
DOI
 


Unger JM, Griffin K, Donaldson GW, Baranowski KM, Good MJ, Reburiano E, Hussain M, Monk PJ, Van Veldhuizen PJ, Carducci MA, Higano CS, Lara PN, Tangen CM, Quinn DI, Wade JL, Iii, Vogelzang NJ, Thompson IM, Jr, Moinpour CM. Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421). J Patient Rep Outcomes. 2018 Jun 13;2:27. doi: 10.1186/s41687-018-0054-5. eCollection 2017.  PMID: 29951640    PMCID: PMC5997724
PubMed
 
PubMed Central
 
DOI
 


Hershman DL, Unger JM, Crew KD, Till C, Greenlee H, Minasian LM, Moinpour CM, Lew DL, Fehrenbacher L, Wade JL 3rd, Wong SF, Fisch MJ, Lynn Henry N, Albain KS. Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715). J Natl Cancer Inst. 2018 Jun 1;110(6):669-676. doi: 10.1093/jnci/djx259.  PMID: 29361042    PMCID: PMC6005110
PubMed
 
PubMed Central
 
DOI
 


Chavez-MacGregor M, Unger JM, Moseley A, Ramsey SD, Hershman DL. Survival by Hispanic ethnicity among patients with cancer participating in SWOG clinical trials. Cancer. 2018 Apr 15;124(8):1760-1769. doi: 10.1002/cncr.31241. Epub 2018 Jan 25.  PMID: 29370458    PMCID: PMC5963502
PubMed
 
PubMed Central
 
DOI